Your account is not claimed yet. You can sign up with ORCID to claim your account.

Silvio Aprile

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

International journal of molecular sciences

Chemical research in toxicology

Università degli Studi del Piemonte Orientale

Università degli Studi del Piemonte Orientale (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi del Piemonte Orientale

Italy

Post-Doc position :: Dipartimento di Scienze del Farmaco

Education History

Università degli Studi del Piemonte Orientale

Italy

PHD :: Dipartimento di Scienze del Farmaco

Publications

Salvatore Villani, Giulia Dematteis, Laura Tapella, Mara Gagliardi, Dmitry Lim, Marco Corazzari, Silvio Aprile, Erika Del Grosso
Quantification of the Chemical Chaperone 4-Phenylbutyric Acid (4-PBA) in Cell Culture Media via LC-HRMS: Applications in Fields of Neurodegeneration and Cancer. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Sara Boumya, Silvia Fallarini, Sonia Siragusa, Giovanni Petrarolo, Silvio Aprile, Valentina Audrito, Concettina La Motta, Silvia Garavaglia, Laura Moro, Giulia Pinton
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment. International journal of molecular sciences 24 (7) (2023)
Francesca Brunelli, Chiara Ceresa, Letizia Fracchia, Gian Cesare Tron, Silvio Aprile
Expanding the Chemical Space of Drug-like Passerini Compounds: Can α-Acyloxy Carboxamides Be Considered Hard Drugs? ACS medicinal chemistry letters 13 (12) (2022)
Celia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, Mauro Vismara, Silvia Maria Grazia Trivigno, Nausicaa Clemente, Silvio Aprile, Federico Alessandro Ruffinatti, Paola Portararo, Nicoletta Filigheddu, Ivan Zaggia, Irene P Bhela, Marta Serafini, Tracey Pirali, Mario Paolo Colombo, Mauro Torti, Sabina Sangaletti, Alessandra Bertoni, Armando A Genazzani
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy. Blood advances 6 (15) (2022)
Irene Preet Bhela, Alice Ranza, Federica Carolina Balestrero, Marta Serafini, Silvio Aprile, Rita Maria Concetta Di Martino, Fabrizio Condorelli, Tracey Pirali
A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs. Journal of medicinal chemistry (2022)
Rebecca Galla, Sara Ruga, Silvio Aprile, Sara Ferrari, Arianna Brovero, Giorgio Grosa, Claudio Molinari, Francesca Uberti
New Hyaluronic Acid from Plant Origin to Improve Joint Protection-An In Vitro Study. International journal of molecular sciences 23 (15) (2022)
Francesca Brunelli, Chiara Ceresa, Letizia Fracchia, Gian Cesare Tron, Silvio Aprile
Expanding the Chemical Space of Drug-like Passerini Compounds: Can α-Acyloxy Carboxamides Be Considered Hard Drugs? ACS medicinal chemistry letters 13 (12) (2022)
Silvio Aprile, Giorgia Colombo, Marta Serafini, Rosanna Di Paola, Federica Pisati, Irene Preet Bhela, Salvatore Cuzzocrea, Giorgio Grosa, Tracey Pirali
An Unexpected Deuterium-Induced Metabolic Switch in Doxophylline. ACS medicinal chemistry letters 13 (8) (2022)
Alberto Massarotti, Francesca Brunelli, Silvio Aprile, Mariateresa Giustiniano, Gian Cesare Tron
Medicinal Chemistry of Isocyanides. Chemical reviews 121 (17) (2021)
Marta Serafini, Celia Cordero-Sanchez, Rosanna Di Paola, Irene P Bhela, Silvio Aprile, Beatrice Purghè, Roberta Fusco, Salvatore Cuzzocrea, Armando A Genazzani, Beatrice Riva, Tracey Pirali
Store-Operated Calcium Entry as a Therapeutic Target in Acute Pancreatitis: Discovery and Development of Drug-Like SOCE Inhibitors. Journal of medicinal chemistry 63 (23) (2020)
Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, Silvia Fallarini
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity. Journal of medicinal chemistry 63 (6) (2020)
Ubaldina Galli, Gian Cesare Tron, Beatrice Purghè, Giorgio Grosa, Silvio Aprile
Metabolic Fate of the Isocyanide Moiety: Are Isocyanides Pharmacophore Groups Neglected by Medicinal Chemists? Chemical research in toxicology 33 (4) (2020)
Marta Serafini, Enza Torre, Silvio Aprile, Alberto Massarotti, Silvia Fallarini, Tracey Pirali
Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors. Molecules (Basel, Switzerland) 24 (10) (2019)

Silvio Aprile.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Silvio Aprile